 |
|
Prostate Cancer ScreeningWhat Family Physicians Believe Is Best
Ronald J. Hicks, MD;
Robert M. Hamm, PhD;
Debra A. Bemben, PhD
Arch Fam Med. 1995;4(4):317-322.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Oesterling J. Prostate-specific antigen: improving its ability to diagnose early prostate cancer. JAMA. 1992;267:2236-2238.
FREE FULL TEXT
2. Lange P. The next era for prostate cancer: controlled clinical trials. JAMA. 1993;269:95-96.
FREE FULL TEXT
3. Dorr V, Williamson S, Stephens R. An evaluation of prostate-specific antigen as a screening test for prostate cancer. Arch Intern Med. 1993;153:2529-2537.
FREE FULL TEXT
4. Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS. Screening for prostate cancer: a decision analytic view. JAMA. 1994;272:773-780.
FREE FULL TEXT
5. Hinman F. Screening for prostatic carcinoma. J Urol. 1991;145:126-129.
PUBMED
6. Lawrence R. Screening for prostate cancer. In: Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions: Report of the US Preventive Services Task Force. Baltimore, Md: Williams & Wilkins; 1989. 7. Hahn D, Roberts R. PSA screening for asymptomatic prostate cancer: truth in advertising. J Fam Pract. 1993;37:432-436.
PUBMED
8. Johansson J, Adami H, Andersson S, Bergstrom R. High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA. 1992;267:2191-2196.
FREE FULL TEXT
9. Kramer B, Brown M, Prorok P, Potosky A, Gohagan J. Prostate cancer screening: what we know and what we need to know. Ann Intern Med. 1993;119:917-923.
10. Mold J, Holtgrave D, Bisonni R, et al. The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis. J Fam Pract. 1992;34:561-568.
PUBMED
11. Mettlin C, Jones G, Averett H, Gusberg S, Murphy G. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. Cancer. 1993;43:42-46.
12. Fair W. Proceeding of a Symposium in Conjunction with the American Urologic Association's 87th Annual Meeting; May, 12, 1992; Washington, DC. AUA Today. 1992:16-19. 13. Sheldon C, Williams R, Fraley E. Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J Urol. 1980;134:626-630.
14. Brawer M, Chetner M, Beatie J. Screening for prostatic carcinoma with prostatespecific antigen. J Urol. 1992;147:841-845.
PUBMED
15. Catalona W, Smith D, Ratliff T. Measurement of prostate-specific antigen results using transrectal ultrasound gland volume: differentiation of benign prostatic hyperplasia and prostate cancer. N Engl J Med. 1991;324:1156-1161.
ABSTRACT
16. Mettlin C, Lee F, Drago J, et al. American Cancer Society National Prostate Cancer Detection Project. Cancer. 1991;67:2949-2958.
PUBMED
17. Puppo P, Perachino M, Ricciotti G, Vitali A. Comparison between digital rectal examination, prostate-specific antigen and transrectal ultrasound in symptomatic patients: results on 141 cases. Eur Urol. 1992;21(suppl_1):87-91.
PUBMED
18. Carter H, Pearson J, Metter J, Brant L, Chan D. Longitudinal evaluation of prostatespecific antigen levels in men with and without prostate disease. JAMA. 1992;267:2215-2220.
FREE FULL TEXT
19. Hudson M, Bahnson R, Catalona WJ. Clinical use of prostate-specific antigen in patients with prostate cancer. J Urol. 1989;142:1011-1017.
PUBMED
20. Lee F, Littrup P, Lof-Christensen L, et al. Predicted prostate-specific antigen results using transrectal ultrasound gland volume: differentiation of benign prostatic hyperplasia and prostate cancer. Cancer. 1992;1992:211-220.
21. SAS Institute Inc. SAS User's Guide: Basics, 1982 Edition. Cary, NC: SAS Institute Inc; 1982. 22. Eddy D. The challenge. JAMA. 1990;263:287-290.
FREE FULL TEXT
23. Voss JD. Prostate cancer, screening, and prostate-specific antigen: promise or peril? J Gen Intern Med. 1994;9:468-474.
PUBMED
|
